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In most primary or continuous cell cultures infected with the Q-fever agent Coxiella burnetii, bacteria are
typically sheltered in phagolysosome-like, large replicative vacuoles (LRVs). We recently reported that only a
small proportion of mouse peritoneal macrophages (PM) infected with a nonvirulent, phase II strain of C.
burnetii developed LRVs and that their relative bacterial load increased only slowly. In the majority of infected
PM, the bacteria were confined to the small vesicles. We show here that nitric oxide (NO) induced by the
bacteria partially accounts for the restricted development of LRVs in primary macrophages. Thus, (i) PM
and bone marrow-derived macrophages (BMM) challenged with phase II C. burnetii produced significant
amounts of NO; (ii) the NO synthase inhibitors aminoguanidine and N-methyl-L-arginine reduced the pro-
duction of NO and increased the frequency of LRVs (although the relative bacterial loads of individual LRVs
did not change, the estimated loads per well increased appreciably); (iii) gamma interferon (IFN-) or the NO
donor sodium nitroprusside, added to BMM prior to or after infection, reduced the development and the
relative bacterial loads of LRVs and lowered the yield of viable bacteria recovered from the cultures; and (iv)
these effects of IFN- may not be entirely dependent on the production of NO since IFN- also controlled the
infection in macrophages from inducible NO synthase knockout mice. It remains to be determined whether NO
reduced the development of LRVs by acting directly on the bacteria; by acting on the traffic, fusion, or fission
of cell vesicles; or by a combination of these mechanisms.
The gram-negative, obligate intracellular bacterium Coxiella
burnetii, a member of the -subdivision of proteobacteria, is
the agent of Q fever in humans; this zoonosis has nearly world-
wide distribution (4, 5, 14, 22, 32, 34, 41). Two phases of the
bacterium have been described: the highly virulent, phase I
organisms, which are found in infected hosts and insect vec-
tors, and the phase II organisms, which are less virulent or
devoid of virulence for mammalian hosts and are obtained by
multiple passages through chicken embryos. Phase II prepara-
tions may not be free of phase I bacteria, possibly accounting
for the reversions described (4, 5, 32; T. Hackstadt, Letter,
Trends Microbiol. 4:341-342, 1996). Once internalized by per-
missive host cells, the bacteria are found in small phagosomes
that shelter a few organisms and fuse with each other and with
other endocytic or phagocytic vesicles; thus, after 2 or more
days, most infected cells display one or more phagoylysosome-
like large replicative vacuoles (LRVs) that may ultimately con-
tain hundreds of closely packed bacteria (5, 22, 24, 33, 43, 44).
Mature C. burnetii phase II LRVs are fusigenic, acidified, and
(acidic) hydrolase-rich and stain for LAMPs, CD43, Rab7, and
autophagic markers (2, 3, 4, 5, 6, 21, 22, 31, 36). When placed
under rather harsh culture conditions, cells infected with C.
burnetii can release, noncytolytically, infective bacteria into the
medium (33, 37); it is not clear, however, that such release
takes place under normal cell culture conditions during log-
phase growth of the intracellular bacteria.
These features describe the infection with phase I or phase
II C. burnetii of primary or continuous cultures of fibroblasts
and epithelial, macrophage-like, or other cell types from dif-
ferent animal species (2, 3, 4, 5, 24, 31, 39, 43). The infection
of primary macrophages, however, may depend on the animal
species and strain and on the phase of the bacterium, although
comparative in vitro infection assays from the same laboratory
may not always be available. Thus, resident peritoneal macro-
phages from guinea pigs and hamsters are reported to be quite
susceptible to infection with phases I and II of C. burnetii
and to develop bacterium-rich large vacuoles (23, 28, 29),
whereas human and mouse primary macrophages may be
less permissive (16, 44). Recently, the involvement of cytokines
in the control of the infection of human monocytes/macro-
phages by C. burnetii has been extensively examined in at-
tempts to explain the microbicidal defects that underlie the
development of chronic human infection with C. burnetii (11,
12, 16).
We recently reported that, whereas essentially all mouse
peritoneal resident macrophages (PM) can be infected with
C. burnetii phase II, few cells develop typical LRVs; in addi-
tion, the relative bacterial loads in these vacuoles, assessed by
fluorescence measurements of DAPI (4,6-diamidino-2-phe-
nylindole)-stained cells, increased at a much slower rate than
in mouse fibroblasts or J774 macrophage-like cells (44). We
show here that small concentrations of NO, induced by C.
burnetii phase II bacteria, directly or indirectly, control the
formation of LRVs in mouse primary macrophages but not,
apparently, the bacterial load within individual LRVs. How-
ever, higher concentrations of NO induced by gamma inter-
feron (IFN-) or generated with sodium nitroprusside (SNP)
can affect both the formation of LRVs and the bacterial mul-
tiplication.
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MATERIALS AND METHODS
Mice. Female BALB/c 7- to 9-week-old mice were provided by the institutional
animal facility (CEDEME). C57BL/6 inducible nitric oxide synthase knockout
(iNOS KO) and wild-type (WT) mice were used; the control mice were kindly
provided by Elaine Rodrigues (UNIFESP).
Cell culture. Resident macrophages (PM) were collected from peritoneal
washouts of mice killed by neck fracture. Cells (1.5  105), attached to 13-mm-
diameter glass coverslips, were placed in 2-cm2 wells of 24-well tissue culture
plates and kept in 0.5 ml of antibiotic-free Dulbecco modified essential medium
containing 15 mM HEPES, 2 g of sodium bicarbonate/liter, 1 mM L-glutamine,
and 5% (vol/vol) fetal bovine serum. Experiments were started 24 h after prep-
aration of the PM cultures.
Bone marrow-derived macrophages (BMM) were generated from bone mar-
row stem cells cultured on 10-cm-diameter “bacteriological” plastic plates for 7
days in RPMI 1640 medium containing 15 mM of HEPES, 2 g of sodium
bicarbonate/liter, and 1 mM L-glutamine and supplemented with 20% fetal
bovine serum and 30% L929 cell conditioned medium (LCCM). Differentiated
BMM were removed from the substrate by vigorous pipetting of ice-cold
phosphate-buffered saline. Cells were counted, added (1.5  105) to glass cov-
erslips inserted in 24-well tissue culture plates, and cultured in RPMI supple-
mented with 10% fetal bovine serum and 5% LCCM. All cultures were kept at
36°C in a 5% CO2 in air atmosphere.
Bacterial preparation and infection of host cells. Clone 4 phase II Nine Mile
strain of C. burnetii bacteria, which are infective for cells but not for mammals,
were provided by Ted Hackstadt (Rocky Mountain Laboratories, National In-
stitute of Allergy and Infectious Disease, National Institutes of Health, Hamil-
ton, Mont.) and handled in a biosafety level II facility (Hackstadt, letter). Infec-
tive inocula were obtained as described previously (43) from confluent Vero cells
infected with C. burnetii for 7 days. Prior to infection, suspensions containing
109 infective bacteria per ml were mildly sonicated at 35 kHz for 15 min at
room temperature to disrupt the aggregates. Macrophage cultures were infected
with ca. 100 infective organisms per cell. After 24 h, infected cultures were
vigorously washed with Hanks balanced salt solution, and the appropriate fresh
medium was added.
Host cell treatments. Unless otherwise stated, the products added to the
cultures were from Sigma Chemical Co., St. Louis, Mo. NO synthesis was inhib-
ited with 1 mM aminoguanidine hemisulfate salt (AG) or with 100 M N G-
methyl-L-arginine (NMMA). Exogenous NO was generated by adding different
FIG. 1. Contrasting features of C. burnetii phase II infection of mouse PM and BMM. Parallel cultures of macrophages were infected for
24 h with C. burnetii phase II; at different times, the cultures were fixed and processed as described in Materials and Methods. (A) Percentage of
cells with LRVs as a function of the duration of infection. Symbols: F, PM; E, BMM. (B) Relative bacterial load in LRVs on days 4 and 6 after
infection. Bars: , PM; , BMM. Data represent the mean  the standard deviation of one representative experiment out of five with similar
results. Asterisks indicate statistically significant differences between PM and BMM (❋, P 	 0.05; ❋❋, P 	 0.01). (C and D) Superimposed
confocal images of DAPI fluorescence (black) and Nomarski differential interference contrast (gray) of a representative PM (C) and BMM (D).
The arrow points to large vacuole. N, cell nuclei. Bar, 10 m.
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concentrations of SNP. Macrophages were activated with 50 ng of mouse recom-
binant IFN- (R&D Systems, Minneapolis, Minn.)/ml. The agents were added to
the culture medium and kept in it until the end of the experiments.
Nitrite determination. The concentration of nitrite (NO2
), the stable oxi-
dized derivative of NO (25) was determined in 100-l aliquots of cell culture
supernatants transferred to 96-well plates. Then, 100 l of Griess reagent solu-
tion (1% sulfanilamide, 0.1% naphthylene diamine dihydrochloride, 2% H3PO4)
was added per well, and the absorbances were measured at 540 nm in a micro-
plate enzyme-linked immunosorbent assay reader. Sodium nitrite diluted in
culture medium was used as standard.
Cell fixation, staining, determination of the percentage of cells with LRVs, and
direct counts of bacteria. At different times after infection, cultures were fixed
for 1 h in 3.5% formaldehyde containing 7.5% sucrose, stained for 15 min with
3.5 M DAPI, washed, and mounted in 50% glycerol (vol/vol). About 500 cells
in each of triplicate coverslips were scored with a 40 objective in an inverted
microscope for the presence or absence of large C. burnetii vacuoles. LRVs were
defined as those with a diameter at least equal to that of the cell nucleus (100
m2). Bacteria in cells devoid of LRVs were directly counted in cultures stained
with DAPI (ca. 100 cells per time point) by using an epifluorescence microscopy
equipped with a PlanApo 100/NA 1.4 oil objective.
Confocal microscopy, image acquisition, and determination of relative C.
burnetii load. Images of fixed and DAPI-stained cells were acquired in a Bio-Rad
1024UV confocal system attached to a Zeiss Axiovert 100 microscope equipped
with a 40 water immersion objective NA 1.2 plan-apochromatic lens and with
differential interference contrast. LaserSharp 1024 version 2.1A from Bio-Rad
was used for image acquisition, and MetaMorph (Universal Imaging Corpora-
tion) version 3.5 was used for image processing. Polygons were drawn onto
digitized images of infected cells, and the relative fluorescence intensity of
DAPI-stained bacteria within the circumscribed areas was determined. Under
the measurement conditions used, the fluorescence intensity within each polygon
is assumed to be proportional to the bacterial load in the region measured as
previously described (43). Between 60 and 90 vacuoles were measured in each of
triplicate coverslips.
Bacterial viability. According to the method used previously results were
presented in terms of focus-forming units (FFU) (12, 24). Infected macrophages
were lysed in H2O, a step that did not reduce the bacterial infectivity; lysates
were sonicated, diluted, and used to infect monolayers of Vero cells, previously
irradiated (1,000 rads) to block cell multiplication. Irradiated Vero cells were
transferred to glass coverslips inserted in the wells of 24-well tissue culture plates
and then cultured in minimal essential medium supplemented with 5% of fetal
bovine serum at 37°C in a 5% CO2 atmosphere. At 4 days after infection, Vero
cells were washed with PBS, fixed, and stained with DAPI as described above. An
epifluorescence microscope equipped with a 40 objective was used to score the
percentage of infected cells. Dilutions chosen for counting contained ca. 10 to
80% infected cells. About 500 cells were scored per coverslip.
Statistical analysis. Each experiment was performed with triplicate sets of
wells. All tabulated or illustrated values are the averages of the triplicates from
one representative experiment from at least three made. Significance of the
differences between means were evaluated by either Student t test or analysis of
variance, both of which were provided by the Microsoft Excel 97 statistics pack-
age. Differences were taken as statistically significant when P was 	0.05 (indi-
cated by an asterisk in the figures) or when P was 	0.01 (indicated by two
asterisks).
RESULTS
C. burnetii LRVs develop more frequently and contain
higher bacterial loads in BMM than in PM. In agreement
with our previous results, only a small proportion of resident
PM infected with C. burnetii developed bacterium-containing
typically LRVs; the remaining cells displayed a variable num-
ber of small vesicles, each enclosing a few bacteria (44). The
numbers of bacteria in BMM that did not develop LRVs
directly counted by epifluorescence microscopy remained rel-
atively constant between days 1 and 6 of infection. The average
numbers of bacteria  the standard errors per cell (n  100
cells) were as follows: 51  5 (1 day), 34  3 (2 days), 47  7
(4 days), and 38  6 (6 days). The data suggest that the C.
burnetii did not appreciably multiply in cells that did not con-
tain LRVs and point to the importance of the vacuoles as sites
of bacterial replication.
In the experiment illustrated in Fig. 1A, the proportion of
cells with LRVs reached a maximum of 11% on day 6 of
infection, whereas in infected BMM it was significantly
higher (19%). In this and other experiments, the maximum
frequency of the LRVs in both cell types was attained by 6 days
of infection.
The relative bacterial loads in LRVs of PM and BMM,
as assessed by fluorescence measurements, increased from
days 4 to 6 (Fig. 1B). The loads attained were, however, sev-
eralfold higher in BMM than in PM, suggesting that the
former are more permissive to the infection (Fig. 1B to D).
The higher permissiveness to infection of BMM has been
reported for other organisms (9, 10, 19, 30).
NO is induced by C. burnetii phase II bacteria in control and
IFN--treated macrophages. We next examined the net pro-
duction of NO by uninfected or infected PM or BMM that
were either treated or not treated with IFN- (Table 1). It can
be seen that (i) in the absence of added bacteria or IFN-,
PM but not BMM produced significant amounts of NO
over 24 h; (ii) treatment with IFN- increased the production
of NO by uninfected PM but not by BMM; (iii) in the
absence of added IFN-, the bacteria induced net NO produc-
tion in both macrophages, although PM released 3-fold
more NO than BMM; and (iv) PM and BMM treated
with both IFN- and bacteria produced high and statistically
similar amounts of NO. Yoshiie et al. have reported that
mouse lung macrophages produced NO when challenged with
C. burnetii phase I (42).
Inhibitors of NO synthase increase the frequency of LRVs
but not their relative bacterial loads. To assess the relationship
of NO production to the infection pattern, we next examined
the effect of NO synthase inhibitors AG or NMMA on the
infection of PM and BMM. Figure 2A shows that the pro-
portion of cells that developed large C. burnetii vacuoles in-
creased in the cultures treated with the inhibitors, suggesting
that NO induced by the bacteria controls the formation of
LRVs. Within the sensitivity of the method, the bacterial loads
in individual LRVs of cells treated with either AG or NMMA
were not statistically different from those of untreated cells,
suggesting that the small amounts of NO induced by the bac-
teria preferentially control vacuolar development rather than
the relative bacterial loads in the LRVs (Fig. 2B). However,
because cells with LRVs contain more bacteria than those
TABLE 1. Effect of IFN- on the production of NO by control or
by C. burnetii phase II-infected BMM or PM
Host cell
Production of NO
(M nitrite/105 macrophages/24 h  SD)
Uninfected Infecteda
No addition With IFN- No addition With IFN-
BMM 0 0 1.8  0.08 12.3  0.20
PM 1.6  0.04 4.1  0.41 6.6  0.20 16.9  0.40
a Macrophages were infected with C. burnetii for 24 h, and nitrite was mea-
sured in the culture supernatants. NO production was inferred from the nitrite
content of culture supernatants. Cells were exposed to IFN- or to control
medium for the duration of the infection.
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without, the total bacterial loads in cultures treated with the
synthase inhibitors were higher than in the untreated controls
(Fig. 2C).
SNP added at the time of infection reduces the development
of and the relative bacterial loads of LRVs. To examine the
effect of exogenous NO on the infection, SNP, an NO-gener-
ating compound, was added to BMM cultures, together with
the bacteria. Figure 3A and B show that the development of
LRVs and their bacterial loads were both reduced by SNP in a
concentration-dependent fashion. The variability associated
with the measurements of rather low vacuolar fluorescence did
not allow us to estimate the concentrations of SNP that could
inhibit the development of LRV without affecting the bacterial
loads. Confocal images of representative LRVs illustrate the
markedly reduced bacterial loads in the few remaining vacu-
oles from cells treated with 50 or 100 M SNP compared to an
untreated control (Fig. 3C, D, and E).
SNP or IFN- added to infected cultures reduce the fre-
quency, relative bacterial loads, and sizes of the LRVs. In this
experiment BMM infected for 4 days were treated for 24 or
48 h with different SNP concentrations or with a single con-
centration of IFN-. In the experiment shown, the percentages
of cells with LRVs (Fig. 4A), the relative bacterial loads (Fig.
4B), and the sizes of the LRVs (Fig. 4C), estimated in the same
preparations, were all significantly reduced by SNP or IFN-
compared to the untreated controls. The shape of the concen-
tration dependence curves suggests that the effects of SNP on
the vacuoles are asymptotic. Furthermore, at low concentra-
tions, SNP appeared to reduce the proportion of cells with
LRVs to a larger extent than their relative bacterial loads. It
may be of interest that IFN- was more active in reducing the
percent of cells with LRVs than were the higher SNP concen-
trations, although the NO produced by the two treatments was
similar (Fig. 4A). The implication seems to be that an addi-
tional NO independent mechanisms underlies the effects of
IFN- on the infection.
Induction of NO does not entirely account for the effects of
IFN- on the development of LRVs and their relative bacterial
loads. Since, as shown in Fig. 3 and 4, treatment of BMM
with SNP or IFN- exerted rather similar effects on infection,
it was of interest to determine the role of NO in the control of
the size and bacterial load of LRVs in IFN--treated cells. In
the experiment shown in Fig. 5, BMM were infected in the
presence of AG or IFN- alone or both of them combined.
Cultures infected in the presence of IFN- produced high
amounts of NO and did not develop LRVs containing the
bacteria (Fig. 5A); however, although LRVs did not develop,
intracellular bacteria were not eliminated, since in nearly all of
the cells DAPI-stained organisms were consistently found
within small vacuoles dispersed throughout the cytoplasm (Fig.
5C).
As shown in Fig. 2, addition of AG alone blocked the pro-
duction of NO and increased the frequency of LRVs. In con-
FIG. 2. Effect of AG or NMMA on the infection of PM or
BMM by C. burnetii phase II bacteria. Cultures were infected for
24 h, washed, and kept in AG- or NMMA-containing medium for the
6 days of the infection. (A) Percentage of cells with LRVs and nitrite
production by control and AG- or NMMA-treated PM and BMM
cultures. (B) Average of the relative bacterial load per LRV. (C) Fluo-
rimetrically estimated total bacterial load per well in the same exper-
iment shown in panels A and B. For clarity, the same nitrite data are
shown in panels A, B, and C. Means  the standard deviations of one
representative experiment from three with similar results. Asterisks
indicate that differences between control (CTR) and treated cultures
(AG or NMMA) were statistically significant (P 	 0.01).
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trast, although they did not produce significant amounts of
NO, macrophages infected in the presence of both IFN- and
AG, developed few LRVs, with a significantly reduced bacte-
rial load in comparison to untreated or AG-treated cells (Fig.
5A, B, D, and E).
IFN- controls infection in BMM from iNOS KO mice.
Since small amounts of NO were still being produced when the
cultures were treated with IFN- plus AG (Fig. 5A and B), we
performed an experiment with BMM from iNOS KO mice
and WT control mice. Cultures were infected in the presence
of IFN- or AG either singly or in combination. At 6 days after
infection, supernatants were collected for measurement of ni-
trite content, macrophages were lysed and lysate dilutions were
plated on irradiated Vero cell monolayers to estimate bacterial
viability (i.e., with regard to the FFU). As expected, WT mac-
rophages treated with IFN- produced relatively large
amounts of NO and reduced C. burnetii viability (Fig. 6A).
Compared to untreated cells, treatment with AG alone in-
creased the overall load of viable bacteria in WT macrophages.
As expected, small amounts of NO were produced by WT
cultures treated with IFN- plus AG, even though C. burnetii
viability did not statistically differ from that of cultures treated
with IFN- alone (P 0.09) and was clearly reduced compared
to untreated cells (Fig. 6A). In contrast to the WT macro-
FIG. 3. Effect of SNP on the frequency of LRVs and their bacterial load in C. burnetii phase II-infected BMM. SNP was added to the cultures
at the time of infection and was kept in the medium until the end of experiment (6 days). The percentages of cells with LRVs (A) and the relative
bacterial loads in the LRVs (B) are shown, together with the production of nitrite, as a function of the SNP concentration. The same nitrite data
are shown in panels A and B as the means  the standard deviations of one representative experiment from three with similar results. Significant
differences between untreated control and treated cultures are indicated (❋, P 	 0.05; ❋❋, P 	 0.01). (C to E) Confocal superimposed images
of DAPI fluorescence (black) and Nomarski differential interference contrast (gray). Images of representative cells illustrate the difference in
bacterial loads inside the large vacuoles (arrow) of cells that were either left untreated (C) or were treated with 50 M (D) or 100 M (E) SNP.
N, cell nuclei. Bar, 10 m.
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phages, the treatment of iNOS KO macrophages with AG did
not alter bacterial viability compared to untreated cultures
(Fig. 6B). However, the addition of IFN- to iNOS KO cul-
tures clearly reduced the bacterial viability in a situation where
NO production was undetectable (Fig. 6B). Overall, these re-
sults indicate that the control of C. burnetii infection of mac-
rophages by IFN- involves effector molecules other than NO.
DISCUSSION
This report presents evidence that NO produced by mouse
primary macrophages infected with phase II C. burnetii inhibits
the development of LRVs typically found in other cell types.
The main evidence for the control of LRVs by NO is the
finding that the rather-specific NO synthase inhibitors AG or
NMMA significantly increased the proportion of cells with
LRVs (Fig. 2A). The effects were more striking in PM,
which, in the controls, displayed fewer LRVs and produced
higher quantities of NO than BMM (Fig. 1A and 2A and
Table 1). However, although the relative bacterial load in in-
dividual LRVs in both macrophages was not significantly in-
creased by the inhibitors (Fig. 2B), the total bacterial loads in
the cultures treated by the inhibitors were increased (Fig. 2C).
This is accounted for by the fact that the bacterial loads within
LRVs appeared to be much greater and more difficult to count
visually with any accuracy than those of infected cells devoid of
LRV.
Oxygen reduction products may not be important in the
control of C. burnetii phase II infection by untreated or IFN-
-treated mouse primary macrophages. Our own experiments
involving measurements of H2O2 or the addition of superoxide
dismutase and/or catalase to infected cultures provided no
support for a role for oxygen reduction products in the devel-
opment and the relative bacterial loads of LRVs in untreated
or IFN--treated BMM (data not shown). It has also been
shown that isolated C. burnetii bacteria express superoxide
dismutase and catalase activity (1, 20) and that IFN--treated
monocytes from patients with chronic granulomatous disease
were able to kill C. burnetii phase I (12).
Because NO induced by the bacterium restricted the forma-
tion of LRVs without affecting the relative bacterial loads per
cell, we chose to treat infected cultures with the NO generator
SNP; we also treated infected or uninfected macrophages with
IFN-, a cytokine which, among its other effects, is well known
to increase the production of NO. When either SNP or IFN-
were added with the bacteria and kept in the medium through-
out, they reduced both the frequency and the relative bacterial
loads of LRVs (Fig. 3A and B). However, the intracellular
concentrations and the kinetics of NO generated in the normal
course of infection may have differed from those in SNP- or
IFN--treated cells. Furthermore, since the IFN- effect was
FIG. 4. Effect of SNP or IFN- on established infection of BMM.
At 4 days after C. burnetii infection, cultures were treated with SNP or
IFN-. After 24 or 48 h, supernatants were removed for nitrite deter-
mination, and cells were processed as described in Materials and
Methods. (A) Percentage of cells with LRVs and nitrite in culture
supernatants as a function of SNP concentration or IFN- treatment
for 48 h. (B) Relative bacterial loads in LRVs of macrophages treated
with SNP or IFN- for 24 (gray bars) or 48 h (black bars). (C) Vacuolar
central optical section areas in cells treated with 100 M SNP (‚), 50
ng of IFN-/ml (E), or controls (F) as a function of time. Results are
expressed as the means  standard deviations of one of two experi-
ments. Significant differences between untreated control and treated
cultures are indicated (❋, P 	 0.05; ❋❋, P 	 0.01)
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not fully reversed by synthase inhibitors (Fig. 5) and IFN-
treatment reduced bacterial viability in iNOS KO macrophages
(Fig. 6), mechanisms other than those involving NO may be
operating in the control of C. burnetii infection by IFN- (15,
18, 19, 35).
The finding that NO produced by primary macrophages
inhibited the development of C. burnetii-containing LRV raises
two questions that should be considered in further studies. The
first has to do with the mechanisms by which the bacteria
trigger the production of NO by the macrophages; the second,
with the mechanisms by which NO inhibits the development of
LRVs in the host cells.
Induction of NO may reflect the recognition by macro-
phages of molecular patterns expressed on the surface of C.
burnetii; the bacterial ligand could conceivably be a lipopoly-
saccharide known to be compositionally defective in phase II
compared to (virulent) phase I organisms (22, 41; Hackstadt,
letter). Such molecules might be recognized by CD14, scaven-
ger, Toll-like, or other receptors (7, 11, 17, 26, 40). The
production of NO by macrophages may be also induced or
modulated by cytokines such as tumor necrosis factor alpha, IFN-
/, or interleukin-10, of which the first and last are known to be
produced by human or mouse macrophages infected with C. bur-
netii (12, 16, 39). It should be of interest to compare the produc-
tion of NO and the development of LRVs in primary macro-
phages infected with phase I and phase II bacteria.
FIG. 5. Effect of IFN-, AG, or both on the infection of BMM with C. burnetii phase II. IFN-, AG, or both were added to the cultures,
together with the bacteria, for 24 h. At that time cells were washed and kept in fresh drug-containing medium. At 6 days after infection,
supernatants were collected for nitrite determination and cells processed as described in Materials and Methods. (A) Percentage of cells with LRVs
and nitrite concentration in the same cultures. (B) Relative bacterial load in LRVs and the same nitrite concentration data shown in panel A on
a different scale. Results are presented as the mean the standard deviation of one representative experiment from three experiments with similar
results. Statistically significant differences between untreated control (CTR) and treated cultures are indicated (❋, P 	 0.05; ❋❋, P 	 0.01). (C
to E) Confocal superimposed images of DAPI fluorescence (black) and Nomarski differential interference contrast (gray). The images show cells
from cultures treated with IFN- (C), AG (D), or AG plus IFN- (E). The arrowheads indicate C. burnetii dispersed through the cytoplasm; the
arrows indicate the large vacuole. N, cell nucleus. Bar, 10 m.
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The NO triggered by the bacteria could affect vacuolar de-
velopment by one or two non-mutually exclusive mechanisms:
(i) NO could directly or indirectly target mechanisms of vesicle
traffic, fusion, or fission and/or (ii) it could act on the bacteria
inhibiting the production or the activity of putative secreted
factors responsible for the development and features of the
LRVs (37, 38). With regard to the first hypothesis, recent
studies have shown that numerous macrophage genes can be
directly or indirectly activated or repressed by NO induced by
live or dead M. tuberculosis or inert particles, in control or
IFN--treated BMM (8, 13). However, we are not aware of
any evidence that NO can modulate vesicle fusion in situ or in
cell-free fractions. The finding that the development of Leish-
mania amazonensis parasitophorous vacuoles in mouse pri-
mary macrophages was not affected by treatment with AG,
SNP, or IFN- (D. Z. and C. Barbieri, unpublished results) is
at least compatible with the hypothesis that the effect of NO on
LRVs formation is primarily mediated by an effect on C. bur-
netii. Recently, Howe et al. (24) reported that NO inhibits C.
burnetii phase II multiplication and LRV formation in L929
fibroblasts. Since L929 cells were described as highly permis-
sive to C. burnetii (44), the results may also suggest that NO
acts primarily on the bacteria.
There has been accrued interest in the mechanisms of the
innate and acquired microbicidal activity of macrophages and
other cells toward a variety of intracellular pathogens (7, 17,
26, 27, 40). The findings reported here indicate that alongside
with its microbistatic or microbicidal activity, NO may directly
or indirectly control the development of LRVs, which as in
other models, are likely to provide an optimal environment for
the replication of intracellular pathogens.
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